Months after bursting into the bispecific scene out of nowhere, Janux follows the Merck hype to an ...

Bluebird's new gene therapy among three new EMA OKs ahead of FDA. Zachary Brennan. Senior Editor. Ahead of a usually speedy FDA, the European ...
https://www.google.com/url?rct=j&sa=t&url=https://endpts.com/months-after-bursting-into-the-bispecific-scene-out-of-nowhere-janux-follows-the-merck-hype-to-an-ipo/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNE_9vEZhSPBagDVBHEl6Cj9TbTsFA